| Medcare Equipment Company, Llc | |
| 3203 Fairway Dr, Altoona, Pennsylvania 16602 | |
| (814) 941-1619 |
| Name | Medcare Equipment Company, Llc |
|---|---|
| Organization Name | Medcare Equipment Company Llc |
| Location | 3203 Fairway Dr, Altoona, Pennsylvania 16602 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (814) 941-1619 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Mutations in the p63 protein lead to a number of disorders, but none is as severe as the AEC syndrome. Scientists at Goethe University Frankfurt in collaboration with a research group from the University of Naples Federico II have now discovered that this syndrome resembles diseases such as Alzheimer's, Parkinson's or ALS more closely than it does other p63-based syndromes.
AIDS experts speaking at the XIX International AIDS Conference (AIDS 2012) on Wednesday called for an expansion of HIV care and treatment to all women instead of focusing only on those who are pregnant, the Associated Press reports.
A Mayo Clinic study involving 5,540 patients with metastatic colorectal cancer finds that maintenance chemotherapy after initial treatment is more beneficial for patients whose disease is under control, compared with more aggressive treatment.
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
› Verified 3 days ago
| NPI Number | 1134127996 |
| Organization Name | LEXINGTON TWO INC |
| Doing Business As | HOME HEALTH RESOURCE |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1216 Pl Valley Blvd, Ste B, Altoona, PA 16602 |
| Phone Number | 814-941-1619 |
News Archive
Mutations in the p63 protein lead to a number of disorders, but none is as severe as the AEC syndrome. Scientists at Goethe University Frankfurt in collaboration with a research group from the University of Naples Federico II have now discovered that this syndrome resembles diseases such as Alzheimer's, Parkinson's or ALS more closely than it does other p63-based syndromes.
AIDS experts speaking at the XIX International AIDS Conference (AIDS 2012) on Wednesday called for an expansion of HIV care and treatment to all women instead of focusing only on those who are pregnant, the Associated Press reports.
A Mayo Clinic study involving 5,540 patients with metastatic colorectal cancer finds that maintenance chemotherapy after initial treatment is more beneficial for patients whose disease is under control, compared with more aggressive treatment.
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
› Verified 3 days ago
| NPI Number | 1316127541 |
| Organization Name | LEXINGTON TWO, INC |
| Doing Business As | HOME HEALTH RESOURCE |
| Type | DME Supplier - Parenteral & Enteral Nutrition |
| Address | 1216 Pleasant Valley Blvd, Suite 102, Altoona, PA 16602 |
| Phone Number | 814-941-1619 |
News Archive
Mutations in the p63 protein lead to a number of disorders, but none is as severe as the AEC syndrome. Scientists at Goethe University Frankfurt in collaboration with a research group from the University of Naples Federico II have now discovered that this syndrome resembles diseases such as Alzheimer's, Parkinson's or ALS more closely than it does other p63-based syndromes.
AIDS experts speaking at the XIX International AIDS Conference (AIDS 2012) on Wednesday called for an expansion of HIV care and treatment to all women instead of focusing only on those who are pregnant, the Associated Press reports.
A Mayo Clinic study involving 5,540 patients with metastatic colorectal cancer finds that maintenance chemotherapy after initial treatment is more beneficial for patients whose disease is under control, compared with more aggressive treatment.
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
› Verified 3 days ago
| NPI Number | 1649644808 |
| Organization Name | MEDCARE EQUIPMENT COMPANY, LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3203 Fairway Dr, Altoona, PA 16602 |
| Phone Number | 724-850-6916 |
News Archive
Mutations in the p63 protein lead to a number of disorders, but none is as severe as the AEC syndrome. Scientists at Goethe University Frankfurt in collaboration with a research group from the University of Naples Federico II have now discovered that this syndrome resembles diseases such as Alzheimer's, Parkinson's or ALS more closely than it does other p63-based syndromes.
AIDS experts speaking at the XIX International AIDS Conference (AIDS 2012) on Wednesday called for an expansion of HIV care and treatment to all women instead of focusing only on those who are pregnant, the Associated Press reports.
A Mayo Clinic study involving 5,540 patients with metastatic colorectal cancer finds that maintenance chemotherapy after initial treatment is more beneficial for patients whose disease is under control, compared with more aggressive treatment.
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
› Verified 3 days ago
News Archive
Mutations in the p63 protein lead to a number of disorders, but none is as severe as the AEC syndrome. Scientists at Goethe University Frankfurt in collaboration with a research group from the University of Naples Federico II have now discovered that this syndrome resembles diseases such as Alzheimer's, Parkinson's or ALS more closely than it does other p63-based syndromes.
AIDS experts speaking at the XIX International AIDS Conference (AIDS 2012) on Wednesday called for an expansion of HIV care and treatment to all women instead of focusing only on those who are pregnant, the Associated Press reports.
A Mayo Clinic study involving 5,540 patients with metastatic colorectal cancer finds that maintenance chemotherapy after initial treatment is more beneficial for patients whose disease is under control, compared with more aggressive treatment.
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
› Verified 3 days ago
Barrett Vision Center Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 515 26th St, Altoona, Pennsylvania 16602 Phone: (814) 942-3200 | |
Broad Avenue Pharmacy Llc Type: Pharmacy Location: 2329 Broad Ave, Altoona, Pennsylvania 16601 Phone: (814) 943-1310 | |
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 801 Logan Blvd, Altoona, Pennsylvania 16602 Phone: (814) 942-0545 | |
Central Orthotic & Prosthetic Co In Type: Prosthetic/Orthotic Supplier Location: 1019 Logan Blvd, Altoona, Pennsylvania 16602 Phone: (814) 943-5041 | |
Chartwell Pennsylvania Lp Type: DME Supplier - Parenteral & Enteral Nutrition Location: 1216 Pleasant Valley Blvd, Altoona, Pennsylvania 16602 Phone: (814) 941-0106 |